Sustainability + Impact
For more than a decade, Sofinnova Partners has been investing in companies that apply biotechnology to develop sustainable solutions in agriculture, food, chemicals and materials.
We're an environmental impact strategy, with a focus on early-stage investments, helping entrepreneurs build teams and knowledge networks. We find the right financial and industrial partners so that companies we invest in have multiple options.
| Close | Fund | AMT |
|---|---|---|
| 2012 | Sofinnova Green Seed Fund | €22.5 million |
| 2017 | Sofinnova IB I | €125 million |
| 2021 | Sofinnova IB II | €175 million |
Close: 2012
Fund: Sofinnova Green Seed Fund
AMT: €22.5 million
Close: 2017
Fund: Sofinnova IB I
AMT: €125 million
Close: 2021
Fund: Sofinnova IB II
AMT: €175 million
Video: The Industrial Biotech team explains the investment thesis behind their strategy
Industrial biotech is important for Sofinnova Partners because it is critical to our collective future. Each member of the team is motivated by a desire to bring sustainable solutions to our everyday life.
- Sofinnova Industrial BiotechFor our team, investment is about impact
The Sofinnova Partners Industrial Biotech team has unveiled its inaugural Impact Report, underscoring its conviction that the most successful companies of the next decades will be using what some call deeptech to tackle the environmental challenges humanity faces. Read more or click below to download the full report.
"We could easily live without an Uber. It's not going to change our lives if we just have to flag a taxi. But tomorrow if we run out of food, that's a big problem. If we destroy the environment, that's a big problem."
“Founders need to have force, to be able to move mountains and stay resilient when things are not easy. Creativity and charisma are important, of course, but resilience is a very key feature.”
"If you want to find a deeptech investor, able to make some impact and help you make progress in industrial biotech — Sofinnova is it."
“You need to hire people who are better than you are.”
The
Team
Guillaume Baxter
Principal, Sofinnova Partners Industrial Biotech Strategy
Anna Belousova
Analyst, Sofinnova Partners Industrial Biotech Strategy
Joško Bobanović
Partner, Sofinnova Partners Industrial Biotech Strategy
Anouck Champsaur
Associate, Sofinnova Partners Industrial Biotech Strategy
Michael Krel
Partner, Sofinnova Partners Industrial Biotech Strategy
Denis Lucquin
Partner Emeritus, Sofinnova Partners Industrial Biotech Strategy
Mary McCarthy
Partner, Sofinnova Partners Industrial Biotech Strategy
Companies
Fund iteration
Status
Deal lead
Industrial Biotech
Afyren
Industrial Biotech
Biosyntia
Industrial Biotech
Biotalys
Industrial Biotech
CelluComp
Industrial Biotech
Comet Biorefining
Industrial Biotech
DMC Biotechnologies
Industrial Biotech
DNA Script
Industrial Biotech
Elicit Plant
Industrial Biotech
EnginZyme
Industrial Biotech
GFBiochemicals
Industrial Biotech
Meiogenix
Industrial Biotech
MetGen
Industrial Biotech
Micropep Technologies
Industrial Biotech
Microphyt
Industrial Biotech
Prometheus Materials
Industrial Biotech
Protera
Industrial Biotech
Pyrowave
Crossover & Industrial Biotech
Synthace
Industrial Biotech
Werewool
0 results
Related News
Syngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agriculture
Sofinnova Partners appoints Mary McCarthy as Partner for the firm’s Industrial Biotech Strategy
Microphyt appoints two new directors and confirms its focus on sustainable value creation with a new ESG Advisory Committee
Elicit Plant appoints Pam Marrone and Johan de Saegher to its Board of Directors
Elicit Plant validates on a large scale the performance of its BEST-a product for corn that reduces crops’ water consumption and addresses the challenges of climate change